Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Duan

Showing results (171-180 of 235) with videos related to

Pageof 24
Sort By:
Journal of Medicinal Chemistry|November 1, 2002
Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationshipsJames J-W Duan, Lihua Chen, Zelda R Wasserman, et al.
Genetics and Molecular Research : GMR|November 5, 2015
Significant interaction of APOE rs4420638 polymorphism with HDL-C and APOA-I levels in coronary heart disease in Han Chinese menY Huang, H D Ye, X Gao, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James J-W Duan, Zhonghui Lu, Chu-Biao Xue, et al.
Molecular Psychiatry|January 13, 2006
Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populationsJ Ma, W Qin, X Y Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Cathy Harris, et al.
Genetics and Molecular Research : GMR|July 1, 2015
Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese populationH D Ye, Y R Li, Q X Hong, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2020
Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonistsJames J-W Duan, Bin Jiang, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitorsChu-Biao Xue, Xiao-Tao Chen, Xiaohua He, et al.
Epidemiology and Infection|November 10, 2017
Estimated incidence and number of outpatient visits for seasonal influenza in 2015-2016 in Beijing, ChinaS Wu, L VAN Asten, L Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2007
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humansMingxin Qian, Stephen A Bai, Bernice Brogdon, et al.
Pageof 24

Showing results (171-180 of 235) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|November 1, 2002
Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationshipsJames J-W Duan, Lihua Chen, Zelda R Wasserman, et al.
Genetics and Molecular Research : GMR|November 5, 2015
Significant interaction of APOE rs4420638 polymorphism with HDL-C and APOA-I levels in coronary heart disease in Han Chinese menY Huang, H D Ye, X Gao, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)James J-W Duan, Zhonghui Lu, Chu-Biao Xue, et al.
Molecular Psychiatry|January 13, 2006
Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populationsJ Ma, W Qin, X Y Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2006
Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitorsJohn L Gilmore, Bryan W King, Cathy Harris, et al.
Genetics and Molecular Research : GMR|July 1, 2015
Positive association between PPARD rs2016520 polymorphism and coronary heart disease in a Han Chinese populationH D Ye, Y R Li, Q X Hong, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2020
Discovery of 2,6-difluorobenzyl ether series of phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonistsJames J-W Duan, Bin Jiang, Zhonghui Lu, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitorsChu-Biao Xue, Xiao-Tao Chen, Xiaohua He, et al.
Epidemiology and Infection|November 10, 2017
Estimated incidence and number of outpatient visits for seasonal influenza in 2015-2016 in Beijing, ChinaS Wu, L VAN Asten, L Wang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2007
Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humansMingxin Qian, Stephen A Bai, Bernice Brogdon, et al.
Pageof 24